Moynam Heredeibona

Epidemiological, Therapeutic, and Molecular Challenges of HIV in the Central African Republic: A Literature Review

Laris Michael Dan-Houron Bejendo, Héritier Lango, Clotaire Donatien Rafaï, Wanh-Ingo Hereidebona, Christelle Bobossi, Coreta Baguida Bokia, Moynam Heredeibona, Boniface Koffi & Ernest Lango-Yaya · Microbiology Research Journal International · 2026

Background: Human immunodeficiency virus (HIV) remains a major public health challenge in sub-Saharan Africa. The Central African Republic (CAR) is characterized by a generalized epidemic with persistently high prevalence, ongoing transmission, and significant structural health s...

Open access Research Article 10.9734/mrji/2026/v36i51748

Factors Associated with Virological Failure under Dolutegravir-based Therapy in HIV-1 Infected Patients in the Central African Republic (2023–2025)

Laris Michael Dan-Houron Bejendo, Héritier Obed Lango, Clotaire Donatien Rafaï, Christelle Luce Bobossi, Serge Gbazi, Wanh-Ingo Hissein Hereidebona, Bokia Coretha Baguida, Moynam Heredeibona, Boniface Koffi & Ernest Lango-Yaya · Microbiology Research Journal International · 2026

Introduction: HIV‑1 remains a major public health issue, with a prevalence of 3.5% in the Central African Republic. Dolutegravir (DTG)-based regimens are recommended as first-line therapy due to their high efficacy and resistance barrier, yet virological failure persists, influen...

Open access Research Article 10.9734/mrji/2026/v36i51746